NRx Pharmaceuticals (NRXP) News Today → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free NRXP Stock Alerts $3.04 +0.11 (+3.75%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNRx Pharmaceuticals (NRXP) to Release Earnings on Tuesdayamericanbankingnews.com - May 12 at 3:02 AMNRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Updatemarkets.businessinsider.com - May 8 at 9:58 AMNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024prnewswire.com - May 8 at 8:30 AMNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024prnewswire.com - May 7 at 4:01 PMNRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Datamarketwatch.com - May 6 at 5:34 PMNRx Pharmaceuticals Plans To Seek Accelerated Approval Of NRX-101 - Quick Factsmarkets.businessinsider.com - May 6 at 5:34 PMNRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depressionprnewswire.com - May 6 at 8:30 AMNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depressionprnewswire.com - April 30 at 8:30 AMWhy Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?investorplace.com - April 18 at 8:56 AMNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stockfinance.yahoo.com - April 18 at 8:39 AMNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirementfinance.yahoo.com - April 18 at 8:39 AMNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirementprnewswire.com - April 18 at 8:32 AMNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stockprnewswire.com - April 18 at 8:30 AMNRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal Floramarkets.businessinsider.com - April 17 at 10:07 AMNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infectionsfinance.yahoo.com - April 17 at 10:07 AMNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)prnewswire.com - April 15 at 8:30 AMNRx Pharmaceuticals Advances in Breakthrough Bipolar Depression Treatmentmsn.com - April 14 at 7:15 PMShort Interest in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Declines By 88.6%marketbeat.com - April 10 at 9:59 PMNRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Studymarkets.businessinsider.com - April 8 at 11:23 AMNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depressionprnewswire.com - April 8 at 8:30 AMNew Brain Cap Lets People Play Video Games With Their Mindsmsn.com - April 3 at 9:19 PMRep. Raúl Grijalva announces cancer diagnosisca.news.yahoo.com - April 3 at 4:56 AMWoman, 23, diagnosed with cancer after thinking she was bloated with irritable bowel syndromeca.news.yahoo.com - April 3 at 4:56 AMAlberta creating 2 mental health and addictions organizations, including Crown corporationca.news.yahoo.com - April 2 at 6:55 PMThere’s Nothing Wrong With Having Hooded Eyesmsn.com - April 2 at 6:55 PMA dietitian explains how a 'diet break' can make it easier to lose weight and keep it offmsn.com - April 2 at 6:55 PMNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 2 at 1:55 PMmarketbeat.com - April 2 at 6:01 AMNRx Pharmaceuticals reports Q4 resultsmsn.com - April 1 at 12:48 PMNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateprnewswire.com - April 1 at 8:28 AMNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listingfinanznachrichten.de - March 28 at 1:25 PMNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlightsfinance.yahoo.com - March 28 at 8:23 AMNRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listingprnewswire.com - March 28 at 8:00 AMNRx Pharmaceuticals Set to Unveil Fourth Quarter and Full Year 2023 Financial Resultsmsn.com - March 27 at 10:22 PMUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024finance.yahoo.com - March 27 at 1:30 AMNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UKfinance.yahoo.com - March 25 at 4:39 PMNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholdersfinanznachrichten.de - March 22 at 10:45 AMNRx Pharmaceuticals (NRXP) Set to Announce Quarterly Earnings on Thursdaymarketbeat.com - March 22 at 10:28 AMNRx Pharmaceuticals Forges Key Alliances to Bolster Ketamine Supply for Mental Health Treatmentmsn.com - March 21 at 7:06 PMNRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024prnewswire.com - March 21 at 4:02 PMNRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholdersprnewswire.com - March 21 at 1:57 PMNRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holdersmsn.com - March 18 at 10:24 AMNRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholdersfinance.yahoo.com - March 18 at 10:24 AMNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Salesfinanznachrichten.de - March 12 at 11:18 AMNRx unveils plan to battle naked short selling in sharesmsn.com - March 12 at 11:18 AMNRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Salesprnewswire.com - March 12 at 7:49 AMNRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)prnewswire.com - March 11 at 8:30 AMNRXP Apr 2024 2.000 callfinance.yahoo.com - March 9 at 10:52 PMNRXP Apr 2024 1.000 callfinance.yahoo.com - March 7 at 1:38 PMNRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depressionprnewswire.com - March 4 at 8:30 AM Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here NRXP Media Mentions By Week NRXP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼0.610.58▲Average Medical News Sentiment NRXP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼82▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theratechnologies News Enlivex Therapeutics News Acurx Pharmaceuticals News Daré Bioscience News Aprea Therapeutics News Acasti Pharma News Unity Biotechnology News Viracta Therapeutics News Lipocine News Biora Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
